The identification of strategies to promote the enzymatic activity of WHSC1 in colon tumors thus appeared as a promising strategy to trigger selectively the antitumor properties of IFNγ in colon tumors without enhancing its potential involvement in immunosuppressive processes [69]. This evidence concerns the gene NSD2 and colonic neoplasm.